Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Multiplex Assay Market size is estimated to value US$ 3.9 billion in 2023 representing a compound annual growth rate (CAGR) of 9.1%. The factors that contribute to the growth of the market, are the increase in the prevalence of chronic & infectious diseases such as respiratory infections, sexually transmitted infections, gastrointestinal infections, and others. Also, the covid-19 impacted market growth raising awareness of early diagnosis, and advantages over the singleplex & traditional assay, as multiplex assay is used to measure the multiple biomarkers to tailor the treatment for personalized medicine, and detection of multiple pathogens in an automated process, which became more efficient & cost-effective. Further, demand for multiplex assay for R&D from research institutions, and pharmaceutical & biotechnology companies, is expected to boost market growth over the forecast period. Despite the promising growth prospects, the global multiplex assay market also faces certain challenges with limited resources like high investment costs, lack of skilled personnel for data analysis, and regulatory hurdles.
Study Period
2024-30Base Year
2023CAGR
9.1%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The rising demand for accurate & efficient, and reduced sample volume requirements, will attract multiplex assays over traditional single-plex assays for the detection of infectious diseases, and monitoring of chronic diseases such as cancer, diabetes, and autoimmune disorders at early stages, with technological advancements for developing the new assay platforms and biomarkers for the continuously improving the speed of these assay to increase R&D activities and also to develop the personalized medicines. Emerging markets, such as Asia Pacific and Latin America, are expected to present significant growth opportunities due to rising healthcare expenditure, increasing awareness of advanced diagnostics, and growing government support for healthcare infrastructure development.
Based on regions, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. The Asia Pacific region is the fastest-growing regional segment of the multiplex panels market. This is due to the increasing economic growth in the region, as well as the rising demand for advanced healthcare services. North America is expected to hold the major market share during the estimated period and it is likely to remain the largest segment in the coming years. The growth can be attributed to the high adoption rate of new technologies, as well as the presence of a large number of leading players in the multiplex panels market. In addition, Europe is the second-largest regional segment of the market, and it is expected to grow at a significant rate in the coming years owing to the increasing demand for healthcare services in Europe, as well as the growing adoption of personalized medicine.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-30 |
|
Market Size in 2023 |
US$ 3.9 billion |
|
Market CAGR |
9.1% |
|
By Type |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The global multiplex assays market size was valued at US$ 3.9 billion in 2023 and is projected to grow at a CAGR of 9.1% from 2024 to 2030.
Fisher Scientific Inc, Illumina Inc, Bio Rad Laboratories Inc, Qiagen, Abcam plc,
Asia-Pacific is the fastest growing and North America is the dominant market in global multiplex assay market
| 1.Executive Summary |
| 2.Global Multiplex Assays Market Introduction |
| 2.1.Global Multiplex Assays Market - Taxonomy |
| 2.2.Global Multiplex Assays Market - Definitions |
| 2.2.1.Type |
| 2.2.2.End User |
| 2.2.3.Region |
| 3.Global Multiplex Assays Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Multiplex Assays Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Multiplex Assays Market By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Cell-based Multiplex Assays |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Protein Multiplex Assays |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Nucleic Acid Multiplex Assays |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Multiplex Assays Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Hospital & Clinics |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Research Institutions |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Pharmaceutical & Biotechnology Companies |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Diagnostic Laboratories |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Multiplex Assays Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Multiplex Assays Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Cell-based Multiplex Assays |
| 8.1.2.Protein Multiplex Assays |
| 8.1.3.Nucleic Acid Multiplex Assays |
| 8.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Hospital & Clinics |
| 8.2.2.Research Institutions |
| 8.2.3.Pharmaceutical & Biotechnology Companies |
| 8.2.4.Diagnostic Laboratories |
| 8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Multiplex Assays Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Cell-based Multiplex Assays |
| 9.1.2.Protein Multiplex Assays |
| 9.1.3.Nucleic Acid Multiplex Assays |
| 9.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Hospital & Clinics |
| 9.2.2.Research Institutions |
| 9.2.3.Pharmaceutical & Biotechnology Companies |
| 9.2.4.Diagnostic Laboratories |
| 9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 10.Asia Pacific (APAC) Multiplex Assays Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Cell-based Multiplex Assays |
| 10.1.2.Protein Multiplex Assays |
| 10.1.3.Nucleic Acid Multiplex Assays |
| 10.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Hospital & Clinics |
| 10.2.2.Research Institutions |
| 10.2.3.Pharmaceutical & Biotechnology Companies |
| 10.2.4.Diagnostic Laboratories |
| 10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Multiplex Assays Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Cell-based Multiplex Assays |
| 11.1.2.Protein Multiplex Assays |
| 11.1.3.Nucleic Acid Multiplex Assays |
| 11.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Hospital & Clinics |
| 11.2.2.Research Institutions |
| 11.2.3.Pharmaceutical & Biotechnology Companies |
| 11.2.4.Diagnostic Laboratories |
| 11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Multiplex Assays Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Cell-based Multiplex Assays |
| 12.1.2.Protein Multiplex Assays |
| 12.1.3.Nucleic Acid Multiplex Assays |
| 12.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Hospital & Clinics |
| 12.2.2.Research Institutions |
| 12.2.3.Pharmaceutical & Biotechnology Companies |
| 12.2.4.Diagnostic Laboratories |
| 12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Luminex Corporation - A Diasorin Company (US) |
| 13.2.2.Thermo Fisher Scientific (US) |
| 13.2.3.Illumina (US) |
| 13.2.4.Bio-Rad laboratories |
| 13.2.5.QIAGEN (Netherlands) |
| 13.2.6.Merck KGaA (Germany) |
| 13.2.7.Agilent Technologies |
| 13.2.8.MESO SCALE DIAGNOSTICS, LLC. |
| 13.2.9.RANDOX LABORATORIES LIMITED |
| 13.2.10.BioTechne |
| 13.2.11.Olink Proteomics (Sweden) |
| 13.2.12.Diasorin S.p.A. (Italy) |
| 13.2.13.BD(US) |
| 13.2.14.Abcam plc (UK) |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.